Phase II Global Primary Sclerosing Cholangitis (PSC) Study

Office setting

This phase II primary sclerosing cholangitis (PSC) study enrolled patients across 52 sites and 5 countries. PatentWing contributed 32% of United States enrollments and 10% of global enrollments.

Download this case study

Lorem ipsum
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.